The APAC Artificial Organs and Bionics Market can be segmented on the basis of product, technology, material, end-user, company and country. The product segment is further divided into artificial heart, artificial kidney, artificial thyroid gland, bionic limb, ear bionic, artificial lung, artificial womb and others. Artificial kidneys held the dominant share in 2019, on account of increasing renal diseases. Kidney failure leads to incompetent filtration of blood, which calls for kidney replacement, eventually increasing the market share for the artificial kidneys segment. Based on country, Japan holds the maximum share of the market in the entire APAC as it is developed enough to carry out transplantations with the assistance of their professional doctors and staff.
Major players in the APAC Artificial Organs and Bionics Market include Medtronic, Getinge AB, Ekso Bionics Holdings Inc., Boston Scientific Corporation, A biomed, Rex Bionics, Ossur, ReWalk, Cyberdyne Inc., Blatchford, Obara Kogyo Inc. Ltd., Artificial Limbs Manufacturing Corporation of India, Otto Bock, Jarvik Heart, SynCardia Systems, Zimmer Biomet, Cochlear Limited, Roche Holding AG, Gembro AB, Lifenet Health, etc. Collaboration and mergers with medical schools or research organizations is one of the key strategies of the companies to sustain and maintain their position in such highly competitive environment.
Years considered for this report:
- Historical Years: 2015-2018
- Base Year: 2019
- Estimated Year: 2020
- Forecast Period: 2021–2025
- To analyze and forecast the market size of the APAC Artificial Organs and Bionics Market.
- To classify and forecast the APAC Artificial Organs and Bionics Market based on product, technology, material, end-user, company and country.
- To identify drivers and challenges for the APAC Artificial Organs and Bionics Market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the APAC Artificial Organs and Bionics Market.
- To conduct pricing analysis for the APAC Artificial Organs and Bionics Market.
- To identify and analyze the profile of leading players operating in the APAC Artificial Organs and Bionics Market.
The author calculated the market size of the APAC Artificial Organs and Bionics Market by using a bottom-up approach, wherein the data for various end-user segments was recorded and forecast for the future years. The author sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.
Key Target Audience:
- Hospitals, surgical centers, organ banks/distributors and other stakeholders
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to artificial organs and bionics
- Market research and consulting firms
In this report, the APAC Artificial Organs and Bionics Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Market, By Products:
- Artificial Heart
- Artificial Kidneys
- Artificial Thyroid Gland
- Bionic Limb
- Ear Bionic
- Artificial Lung
- Artificial Womb
- Suction Technology
- Implanted myoelectric sensor (IMES) technology
- Socket-Based Technology
- 3D Bioprinting
- Living matter
- Surgical Centers
- South Korea
Company Profiles: Detailed analysis of the major companies present in the APAC Artificial Organs and Bionics Market.
With the given market data, the author offers customizations according to a client’s specific needs.
This report will be delivered within 3 business days and will include the latest impact analysis of COVID-19.
2. Research Methodology
3. Executive Summary
4. Voice of Customer
5. APAC Artificial Organs and Bionics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value & Volume
5.2. Market Share & Forecast
5.2.1. By Products (Artificial heart, Artificial Kidneys, Artificial Thyroid Gland, Bionic Limb, Ear Bionic, Artificial Lung, Artificial Womb and Others)
5.2.2. By Technology (Suction Technology, Implanted myoelectric sensor (IMES) technology, Socket-Based Technology, 3D Bioprinting and Others)
5.2.3. By Material (Mechanical (Plastics, Metal), Biomechanical (Living matter and polymer), Biological)
5.2.4. By End-User (Hospitals, Surgical Centers and Others)
5.2.5. By Company (2019)
5.2.6. By Country
5.3. Market Attractiveness Index
5.4. APAC: Country Analysis
5.4.1. China Artificial Organs and Bionics Market Outlook
22.214.171.124. Market Size & Forecast
126.96.36.199.1. By Value
188.8.131.52. Market Share & Forecast
184.108.40.206.1. By Products
220.127.116.11.2. By Technology
18.104.22.168.3. By Material
22.214.171.124.4. By End-User
5.4.2. India Artificial Organs and Bionics Market Outlook
126.96.36.199. Market Size & Forecast
188.8.131.52.1. By Value
184.108.40.206. Market Share & Forecast
220.127.116.11.1. By Products
18.104.22.168.2. By Technology
22.214.171.124.3. By Material
126.96.36.199.4. By End-User
5.4.3. Japan Artificial Organs and Bionics Market Outlook
188.8.131.52. Market Size & Forecast
184.108.40.206.1. By Value
220.127.116.11. Market Share & Forecast
18.104.22.168.1. By Products
22.214.171.124.2. By Technology
126.96.36.199.3. By Material
188.8.131.52.4. By End-User
5.4.4. South Korea Artificial Organs and Bionics Market Outlook
184.108.40.206. Market Size & Forecast
220.127.116.11.1. By Value
18.104.22.168. Market Share & Forecast
22.214.171.124.1. By Products
126.96.36.199.2. By Technology
188.8.131.52.3. By Material
184.108.40.206.4. By End-User
5.4.5. Singapore Artificial Organs and Bionics Market Outlook
220.127.116.11. Market Size & Forecast
18.104.22.168.1. By Value
22.214.171.124. Market Share & Forecast
126.96.36.199.1. By Products
188.8.131.52.2. By Technology
184.108.40.206.3. By Material
220.127.116.11.4. By End-User
5.4.6. Australia Artificial Organs and Bionics Market Outlook
18.104.22.168. Market Size & Forecast
22.214.171.124.1. By Value
126.96.36.199. Market Share & Forecast
188.8.131.52.1. By Products
184.108.40.206.2. By Technology
220.127.116.11.3. By Material
18.104.22.168.4. By End-User
6. Market Dynamics
7. Market Trends & Developments
8. Competitive Landscape
8.1. Competition Outlook
8.2. Players Profiled (Leading Companies)
8.2.2. Getinge AB
8.2.3. Ekso Bionics Holdings Inc.
8.2.4. Boston Scientific Corporation
8.2.5. A biomed
8.2.6. Rex Bionics
8.2.9. Cyberdyne Inc.
8.2.11. Obara Kogyo Inc. Ltd.
8.2.12. Artificial Limbs Manufacturing Corporation of India
8.2.13. Otto Bock
8.2.14. Jarvik Heart
8.2.15. SynCardia Systems
8.2.16. Zimmer Biomet
8.2.17. Cochlear Limited
8.2.18. Roche Holding AG
8.2.19. Gembro AB
8.2.20. Lifenet Health
9. Strategic Recommendations
10. About the author & Disclaimer
- Getinge AB
- Ekso Bionics Holdings Inc.
- Boston Scientific Corporation
- A biomed
- Rex Bionics
- Cyberdyne Inc.
- Obara Kogyo Inc. Ltd.
- Artificial Limbs Manufacturing Corporation of India
- Otto Bock
- Jarvik Heart
- SynCardia Systems
- Zimmer Biomet
- Cochlear Limited
- Roche Holding AG
- Gembro AB
- Lifenet Health